Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Mycobacterium tuberculosis causes pulmonary tuberculosis (TB) and claims ~1.8 million human lives per annum. Host nitric oxide (NO) is important in controlling TB infection. M. tuberculosis WhiB1 is a NO-responsive Wbl protein (actinobacterial iron-sulfur proteins first identified in the 1970s). Until now, the structure of a Wbl protein has not been available. Here a NMR structural model of WhiB1 reveals that Wbl proteins are four-helix bundles with a core of three α-helices held together by a [4Fe-4S] cluster. The iron-sulfur cluster is required for formation of a complex with the major sigma factor (σ) and reaction with NO disassembles this complex. The WhiB1 structure suggests that loss of the iron-sulfur cluster (by nitrosylation) permits positively charged residues in the C-terminal helix to engage in DNA binding, triggering a major reprogramming of gene expression that includes components of the virulence-critical ESX-1 secretion system.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741622PMC
http://dx.doi.org/10.1038/s41467-017-02418-yDOI Listing

Publication Analysis

Top Keywords

wbl protein
12
structure wbl
8
iron-sulfur cluster
8
protein implications
4
implications sensing
4
tuberculosis
4
sensing tuberculosis
4
tuberculosis mycobacterium
4
mycobacterium tuberculosis
4
tuberculosis pulmonary
4

Similar Publications

Unlabelled: WhiB-like (Wbl) family proteins are a group of small iron-sulfur ([4Fe-4S]) cluster-containing transcription factors and are uniquely found in Actinobacteria and actinobacteriophages. They play pivotal roles in diverse biological processes, including cell development, redox stress response and antibiotic resistance. However, the lack of a canonical DNA binding motif in most Wbl proteins has long obscured the mechanistic understanding of how Wbl family proteins regulate gene expression.

View Article and Find Full Text PDF

Overexpression of the Wbl family regulator whiD modulates secondary metabolite biosynthesis in Streptomyces.

World J Microbiol Biotechnol

May 2025

State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing, 100193, China.

Streptomyces species are prolific producers of a diverse array of bioactive secondary metabolites (SMs), which constitute approximately two-thirds of natural product-based pharmaceuticals with significant clinical, agricultural, and biotechnological applications. However, the regulatory mechanisms underlying the biosynthesis of these compounds remain poorly understood, impeding the development of high-yielding strains for industrial production. Herein, we investigated the role of the WhiB-like (Wbl) family transcriptional regulator, WhiD, in modulating SM production in Streptomyces bingchenggensis BC04.

View Article and Find Full Text PDF

Background: The conventional lymphocyte crossmatch (XM) assay necessitates mononuclear cell isolation. In our previous work, we introduced a novel 3-laser, 4-color flow cytometric (FC) XM protocol utilizing whole blood lysis (WBL) and CD45 fluorescence-triggered acquisition to detect human leukocyte antigen (HLA) antibody binding. Building on this, we aimed to adapt these advancements for complement-dependent cytotoxicity (CDC) XM using FC (FCCDC).

View Article and Find Full Text PDF

Elucidating details of biology's selective uptake and trafficking of rare earth elements, particularly the lanthanides, has the potential to inspire sustainable biomolecular separations of these essential metals for myriad modern technologies. Here, we biochemically and structurally characterize () LanD, a periplasmic protein from a bacterial gene cluster for lanthanide uptake. This protein provides only four ligands at its surface-exposed lanthanide-binding site, allowing for metal-centered protein dimerization that favors the largest lanthanide, La.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated differences in IDH-mutant gliomas across different age groups (pediatric, young adult, and older adult) to better understand their clinical and genomic characteristics.
  • Young adult patients experienced shorter progression-free survival (PFS) and time to malignant transformation compared to pediatric and older adult patients, but their overall survival (OS) rates were similar.
  • The results suggest that treatment strategies and outcomes for glioma patients should be tailored based on age, indicating a need for further investigation into age-related factors affecting these tumors.
View Article and Find Full Text PDF